Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 0.00% | 54.95 | 0.9% | $2134.82m | |
| JNJ | Johnson & Johnson | -0.02% | 167.80 | 0.7% | $981.75m | |
| ABBV | AbbVie, Inc. | 0.02% | 135.89 | 1.9% | $880.45m | |
| MRK | Merck & Co., Inc. | -0.01% | 81.37 | 0.7% | $851.92m | |
| BMY | Bristol-Myers Squibb Co. | 0.03% | 64.95 | 1.0% | $676.65m | |
| LLY | Eli Lilly & Co. | 0.01% | 244.15 | 1.1% | $623.70m | |
| AZN | AstraZeneca Plc | 0.00% | 58.85 | 1.0% | $232.31m | |
| NVS | Novartis AG | 0.01% | 90.56 | 0.2% | $204.60m | |
| NVO | Novo Nordisk A/S | 0.02% | 96.34 | 0.1% | $165.68m | |
| VTRS | Viatris, Inc. | 0.00% | 15.22 | 0.0% | $148.94m | |
| GSK | GlaxoSmithKline Plc | 0.00% | 45.47 | 0.2% | $142.24m | |
| RGEN | Repligen Corp. | 0.00% | 193.26 | 6.7% | $98.44m | |
| IMMX | Immix Biopharma, Inc. | 0.00% | 5.84 | 0.0% | $95.50m | |
| ALLK | Allakos, Inc. | 0.00% | 7.64 | 0.0% | $93.56m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.14% | 122.00 | 0.0% | $74.51m |
Company Profile
Annovis Bio, Inc. is a clinical stage drug platform company, which develops drugs to treat neurodegeneration. The firm compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also develops ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.